Home | In Re Celgene Corporation Securities Litigation This is the Celgene Corporation Securities Litigation SUMMARY OF THE ACTION AND SETTLEMENT The information contained on this website is only a summary of the information presented in more detail in the Notice of (I) Proposed Class Action Settlement; (II) Settlement Hearing; and (III) Motion for Attorneys’ Fees and Litigation Expenses ("Settlement Notice") Because this website is just a
Celgene Settlement Notice This Notice concerns a proposed settlement of a securities class action (“Action”) The Action alleges that Celgene and certain of its officers, Terrie Curran and Philippe Martin (together, “Defendants”), violated the federal securities laws by making false and misleading statements during the Class Period regarding certain Celgene products and product candidates, including the
DISTRICT OF NEW JERSEY IN RE CELGENE CORPORATION Case No. 2:18-cv-04772 . . . UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY IN RE CELGENE CORPORATION SECURITIES LITIGATION Case No 2:18-cv-04772 (MEF) (JBC) CLASS ACTION RATION IN SUPPORT OF PLA NTIFF'S UNOPPOSED MOTION FOR PRELIMINARY APPROVAL OF SETTLEMENT AND A